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Background: Human papilloma virus (HPV) is emerging as the primary cause for some head and neck cancers. The
objective of this study was to investigate the association between head and neck cancer (HNC) survival and
socioeconomic status (SES) in Canada, and to investigate changes in the relationship between HNC survival and SES
from 1992 to 2005.
Methods: Cases were drawn from the Canadian Cancer Registry (1992–2005), and were categorized into three
subsites: oropharynx, oral cavity, and “other” (hypopharynx, larynx, and nasopharynx). Demographic and
socioeconomic information were extracted from the Canadian Census of Population data for the study period,
which included three census years: 1991, 1996 and 2001. We linked cases to income quintiles (InQs) according to
patients’ postal codes.
Results: Overall survival, without controlling for smoking, for oropharyngeal cancer increased dramatically from
1992–2005 in Canada. This increase in survival for oropharynx cancer was eliminated by the introduction of controls
for smoking. Survival for all head and neck cancer subsites was strongly correlated with SES, as measured by
income quintile, with lower InQ’s having lower survival than higher. Lastly, the magnitude of the difference in
survival between the highest and lowest income quintiles increased significantly over the time period studied for
oropharynx cancer, but did not statistically significantly change for oral cavity cancer or other head and neck
cancers.
Conclusions: These data confirm a significant impact of socioeconomic deprivation on overall survival for head
and neck cancers in Canada, and may provide indirect evidence that HPV-positive head and neck cancers are more
common in higher socioeconomic groups.
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Head and neck cancer (HNC) accounts for approximately
3% of all new malignancies in the United States, and is the
fifth most common human cancer worldwide. In 2012
there were approximately 52,610 new cases in the United
States, and 11,500 deaths from HNC [1]. Many cancers
have been demonstrated to have worse survival in patients
with lower socio-economic status [2]. The reasons for this
relationship are multifactorial, and may include stage at* Correspondence: sjohnsonobaseki@gmail.com
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reproduction in any medium, provided the orpresentation, education [3], access to health care services,
diet, environmental exposures, and differential levels of to-
bacco and alcohol consumption. Booth et al examined the
effects of median household income on survival for a
number of cancers in Ontario Canada, including head and
neck, and found a substantial gradient in survival between
the highest and lowest income quintiles for all cancers
studied [4].
A number of studies have examined the relationship
between survival and socioeconomic status for HNCs in
general and/or specific head and neck subsites. In 1999,
Rachet et al. looked at survival for laryngeal cancer in
England and Wales, and found that five-year survivaltral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in the most deprived group than those in the most afflu-
ent group [5]. This was the steepest socioeconomic gra-
dient they found in all of the 20 common cancers they
examined in this fashion. Chu et al examined Asian and
Pacific Islanders in the United States using California
Cancer Registry data from 1998–2007, and found that
lower neighborhood SES was significantly associated
with poorer disease specific and overall survival after
adjusting for patient and tumor characteristics across all
head and neck subsites [6]. Jovanovic-Andersen et al.
also found lower survival with lower socioeconomic pos-
ition as measured by a number of different parameters
across head and neck subsites in Denmark [7]. For oro-
pharyngeal cancer specifically, Reitzel et al. identified
poor overall survival among patients from highly de-
prived neighborhoods relative to less deprived neighbor-
hoods in the United States [8].
There has been some literature examining the survival –
SES relationship for cancer in Canada as well. Boyd et al.
examined all incident cases of cancer in Ontario using the
Ontario Cancer Registry from 1987–1992 and compared
this with the Surveillance, Epidemiology, and End Result
(SEER) Database in the United States [9]. For HNC, they
found a 7.4% difference (CI 3.1%-11.7%) between the high-
est income quintile and the lowest in Ontario, and a 13.7%
difference (CI 11.1%-16.3%) in the United States. The
same group published on SES effects in larynx cancer [10].
They again identified patients using the Ontario Cancer
Registry, and used income quintiles based on median
household income. They found no relationship between
SES and outcome for supraglottic cancer, but there was an
association identified for glottic cancer: the relative risk
for patients in the lowest income quintile was 2.75 (CI
1.48-5.12) for cause-specific death and 1.90 (CI 1.24-2.93)
for loco-regional failure.
Dramatic changes have been seen in the epidemiology
of HNC, particularly oropharynx cancer, in the past two
decades. These changes are related to the increase in the
proportion of HNCs caused by human papilloma virus
(HPV) [11]. HPV-related cancers are known to have in-
creased survival compared to non-HPV-related cancers
in the head and neck [12]. The survival for non-HPV-
related cancers has been relatively stable. What is not
known is whether the relationship between survival and
SES is different for HPV-related cancers as compared to
non-HPV-related cancers. Indirect evidence that the ef-
fect of SES on survival is different based on HPV status
may come from identifying a difference in the SES-
survival effect over time and/or identifying a different
trend in oropharyngeal cancers, as opposed to other
head and neck subsites.
Our group sought to investigate the SES/HNC survival
relationship over the time period 1992–2005. To ourknowledge, there has not been a Canadian study using
nationwide Cancer Registry data to examine the rela-
tionship between HNC survival and SES. The goals of
this study were two-fold: 1) to confirm the relationship
between SES and HNC survival using Canadian Cancer
Registry data; 2) to investigate the changes in the rela-
tionship between SES and HNC survival over time.
Methods
Our data were drawn from three sources: the Canadian
Cancer Registry (CCR) data file, the Vital Statistics (VS)
data file, and the Canadian Census of Population. The
CCR and VS are already linked at the individual level in
the file provided by Statistics Canada to researchers
through the Canadian Research Data Centre Network.
Data were accessed in the New Brunswick Research
Data Centre (NB-RDC) located at the University of New
Brunswick in Fredericton, Canada. Our study complied
with the University of New Brunswick Institutional Review
Board ethics requirements, which do not necessitate an
additional review for research projects using Statistics
Canada data stored in the NB-RDC. The CCR data file
contains patient demographic and tumor-specific data on
each tumor recorded in provincial and territorial cancer
registries from 1992 to 2007, inclusive. In order to be able
to observe survival over a two-year period after diagnosis,
we restrict attention to cancer cases diagnosed in 2005 or
earlier. From the CCR data we obtained the sex of the in-
dividual, the age at which the tumor was diagnosed, and
the individual’s six-digit postal code of residence. Data on
demographic and socioeconomic information at the local
area level were drawn from the Canadian Census of Popu-
lation for the census years (CY) 1991, 1996, and 2001. The
finest level of disaggregation at which census information
is released by Statistics Canada is the Dissemination Area
(DA), a small, stable geographic unit composed of one or
more adjacent blocks, with a population of 400 to 700 per-
sons. DAs cover the whole territory of Canada. For each
DA and for each of the four CYs, information was col-
lected on age for men and women, average household in-
come, and proportion of adult residents with at least a
university degree. Information at the DA level was com-
puted for each CY and assigned to each individual in the
CCR data as follows: cases diagnosed in 1992–1995 were
associated with socioeconomic characteristics according
to the 1991 Census; cases diagnosed in 1996–2000 were
associated with data from the 1996 Census; and cases di-
agnosed in 2001–2005 were associated with data from the
2001 Census. The statistical tool PCCF +was used to map
the six digit postal code available in the CCR data for each
case of HNC to the relevant DA in which that postal code
area was located.
Our key measure of interest was average household in-
come. In order to control for wage and price differences
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each DA was defined relative to other DAs in the associ-
ated Census Division (CD), which Statistics Canada de-
fines as a group of neighboring municipalities joined
together for the purposes of regional planning and man-
aging common services. In addition, although person-
level data on smoking behavior is not available in the
CCR, provincial smoking rates by education level were
obtained for each CY from various waves of the Canadian
Community Health Survey and the National Population
Health Survey. For each DA in our sample and for each
CY, a weighted average DA-level smoking rate was con-
structed using provincial smoking rates by education
level weighted by the share of the adult population in
each DA with that level of education. This composite
smoking rate was included as an additional control vari-
able in the regressions. A more detailed discussion of
both CCR and Census data files and their linkage is avail-
able elsewhere [13].
The dependent variable was a binary variable that
took the value 1 if the individual was still alive two
years after the date of diagnosis and 0 if the individual
was listed in the VS data as having died during that
two-year period. Since we are examining survival over a
two year period by restricting attention to cases diag-
nosed in 2005 and earlier, censoring is not an issue. We
focus on two-year survival rather than five-year survival
in order to have as long a time period as possible over
which to investigate changes in the relationship be-
tween survival and SES. Statistical analysis employed
logistic estimation methods, with the dependent vari-
able expressed as a function of personal characteristics
(sex, age at diagnosis, province of residence, CY of
diagnosis) and DA-level characteristics (income quintile
measured as a set of binary variables and weighted
smoking rates). To allow trends over time in two-year
survival to vary by SES, additional interactions of the
CY indicator variables and the InQ variables were also
included.
The CCR file developed by Statistics Canada for the
Canadian research data centers provides ICD10 codes
that are consistently defined over the whole sample
period from 1992–2007. Of note, base of tongue was in-
cluded in the oropharynx group and not in the oral cav-
ity group. Regressions were estimated separately for
each of three distinct subgroups of HNC, stratified by
likelihood of causation by HPV, as in a prior study from
our group [13]: i) cancers of the oropharynx (ICD-O-2/
3 codes C019, C024, C051, C052, C090-103, C108-109,
C140, and C142); ii) cancers of the oral cavity (C003-4,
C020-C023, C029-C031, C039-C041, C049-50, C059-
C062, and C069); and iii) cancers of the hypopharynx,
larynx, and nasopharynx (C110-C139, C300, and
C310-C329).Results
Overall two-year survival
When examined without smoking controls, the overall
two-year survival for oropharyngeal cancer increased
dramatically between the 1991 CY and 2001 CY (OR
1.46, p = 0.00, CI 1.28-1.66). A similar but smaller mag-
nitude increase in survival was seen for oral cavity can-
cer between the 1991 and 2001 CYs (OR 1.15, p = 0.02,
CI 1.02-1.30), and there was no significant increase in
survival for other HNCs (OR 1.05, p = 0.29, CI 0.96-
1.15) (Table 1). The probability of survival for all three
types of cancer was significantly lower when the age at
diagnosis was older, and was lower for men for oropha-
ryngeal and oral cavity cancers (Table 1). Once smoking
controls were introduced, there was no longer a signifi-
cant increase in survival for any cancer subsite over the
duration of the study period (Oropharynx: OR 1.05, p =
0.64, CI 0.87-1.26; Oral cavity: OR 0.92, p = 0.92, CI
0.80-1.06; Other: 0.92, p = 0.22, CI 0.80-1.05). Higher
smoking rates were also associated with lower incidence
of survival for all three types of cancer, with a ten per-
centage point increase in smoking rate reducing the
odds of survival by 31% for oropharynx (OR 0.69, p =
0.00, CI 0.58-0.81; Oral cavity: OR 0.78, p = 0.00, CI
0.68-0.89; Other: 0.86, p = 0.01, CI 0.76-0.96) (Table 2).
SES status and survival
SES, as measured by income quintile, was strongly and
significantly correlated with survival for all head and
neck subsites. For oropharyngeal cancers, the odds ratio
for survival for the lowest income quintile was 0.62 (p =
0.00, CI 0.52-0.74) compared to the highest income
quintile (Table 3). There was a smooth statistically sig-
nificant increase in survival across all five income quin-
tiles. For oral cavity cancers, the odds ratio for survival
for the lowest income quintile was 0.68 (p = 0.00, CI
0.56-0.82), whereas for all other head and neck subsites
the odds ratio was 0.63 (p = 0.00, CI 0.56-0.70), with the
same statistically significant pattern of increase with in-
creasing income quintile (Table 3).
Time trend for SES/survival relationship
In our final specification, we allowed changes in survival
over time to vary by SES. In this specification the SES
indicator variables correspond to the base census year
1991, while interactions of these SES indicator variables
with CY indicator variables indicate whether the gap in
survival incidence between higher and lower SES widens
or narrows over time. For oropharynx cancers the odds
ratio for survival of the lowest income quintile compared
to the highest income quintile was significantly lower in
2001 than in 1991, as indicated by the interaction term
for the lowest income quintile in 2001(OR 0.72, p = 0.05,
CI 0.52-1.00) (Table 4). That is, the survival advantage
Table 1 Overall 2-year survival for head and neck cancers
Oropharyngeal Oral cavity Naso/hypo/laryngeal
n = 7022 n = 8541 n = 14665
OR p-value 95% CI OR p-value 95% CI OR p-value 95% CI
Male 0.748 0.000 (0.673-0.831) 0.703 0.000 (0.627-0.788) 1.015 0.717 (0.937-1.100)
CY 1991 1.000 1.000 1.000
CY 1996 1.212 0.003 (1.068-1.374) 1.167 0.023 (1.022-1.334) 0.996 0.917 (0.919-1.079)
CY 2001 1.457 0.000 (1.277-1.663) 1.151 0.022 (1.021-1.298) 1.051 0.286 (0.959-1.152)
Age at diagnosis 0.952 0.000 (0.947-0.956) 0.962 0.000 (0.958-0.966) 0.969 0.000 (0.966-0.971)
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study period compared to individuals in the lowest InQ.
Interaction terms for other quintiles in 2001 were also
less than 1 but were not significant. For oral cavity can-
cers, interactions of income quintiles with 1996 and
2001 CYs were also less than 1 but were not significantly
different from the difference in income quintiles at base-
line 1991 CY. For oral cavity cancers, the odds ratio for
the lowest income quintile in 2001 was 72% of that at
baseline but was not significant (OR 0.72, p = 0.14, CI
0.46-1.12). For other HNC, the odds ratio for survival in
2001 for the lowest income quintile compared to the
highest was also not significantly different from the pat-
tern at baseline (OR 0.90, p = 0.56, CI 0.63-1.29)
(Table 4).
Discussion
Our study showed that survival for oropharynx cancer
increased dramatically in Canada from the 1991 to 2001
census years, reflecting cancers diagnosed between 1992
and 2005 (OR 1.46). Survival for oral cavity cancers also
increased, but to a lesser extent (OR 1.15). Survival did
not significantly change for cancers in other head and
neck subsites (OR 1.05). After controlling for smoking
rates, this increase in survival for oropharyngeal and oral
cavity cancers over the time period was no longer
present. We feel there are two likely explanations for
this phenomenon. First, this data was measuring all
cause survival rather than disease specific survival. ItTable 2 Overall 2-year survival for head and neck cancers wit
Oropharyngeal
n = 7022
OR p-value 95% CI OR
Male 0.751 0.000 (0.676-0.833) 0.706
CY 1991 1.000 1.000
CY 1996 0.968 0.691 (0.826-1.135) 1.002
CY 2001 1.045 0.643 (0.868-1.258) 0.922
Age at diagnosis 0.952 0.000 (0.947-0.956) 0.962
Smoking Rate 0.687 0.000 (0.582-0.810) 0.779seems likely that nonsmokers would have improved all
cause survival compared with smokers, independent of
their diagnosis of cancer. Second, there is a strong cor-
relation between improved survival from oropharyngeal
cancer and smoking status; that is, it has been demon-
strated that the improved survival in HPV-positive oro-
pharynx cancers is principally seen in nonsmokers
[12,14]. Thus, the evidence for a survival benefit second-
ary to HPV-positivity might be eliminated once smoking
controls are added.
Our second finding was that socioeconomic status, as
measured by income quintile, was significantly corre-
lated with survival. Individuals in the lowest income
quintile had an odds ratio for overall survival of 0.62
compared to the highest income quintile for oropharyn-
geal cancer; the odds ratio was 0.68 for oral cavity can-
cer, and 0.63 for other HNCs. These data indicate that
even in a country with universal healthcare, socioeco-
nomic disparities have a substantial impact on survival.
This confirms similar findings in other studies of the
Canadian population [4,15].
The third and perhaps most interesting finding from
these data relates to the time trend in the impact of so-
cioeconomic status on survival in these cancers. The gap
in survival between the highest and lowest income quin-
tiles increased significantly over the time period studied
for oropharyngeal cancer (the odds ratio for the lowest
income quintile compared to the highest in the 2001 CY
was only 72% of the equivalent odds ratio in 1991. (p =h smoking controls
Oral cavity Naso/hypo/laryngeal
n = 8541 n = 14665
p-value 95% CI OR p-value 95% CI
0.000 (0.629-0.791) 1.018 0.666 (0.939-1.103)
1.000
0.975 (0.882-1.138) 0.907 0.073 (0.815-1.009)
0.254 (0.803-1.060) 0.917 0.216 (0.800-1.052)
0.000 (0.959-0.966) 0.969 0.000 (0.966-0.972)
0.000 (0.684-0.887) 0.857 0.009 (0.764-0.960)
Table 3 Socio-economic status and 2-year survival for head and neck cancers
Oropharyngeal Oral cavity Naso/hypo/laryngeal
n = 7022 n = 8541 n = 14665
OR p-value 95% CI OR p-value 95% CI OR p-value 95% CI
Male 0.743 0.000 (0.669-0.826) 0.707 0.000 (0.631-0.792) 1.007 0.860 (0.928-1.094)
CY 1991 1.000 1.000 1.000
CY 1996 1.025 0.750 (0.879-1.197) 1.054 0.443 (0.922-1.205) 0.958 0.439 (0.860-1.068)
CY 2001 1.147 0.133 (0.959-1.372) 1.002 0.981 (0.856-1.172) 1.009 0.902 (0.876-1.161)
Age at diagnosis 0.952 0.000 (0.948-0.957) 0.963 0.000 (0.959-0.966) 0.969 0.000 (0.966-0.972)
Smoking Rate 0.759 0.001 (0.645-0.892) 0.851 0.015 (0.747-0.970) 0.941 0.326 (0.833-1.063)
Highest InQ 1.000 1.000 1.000
2nd InQ 0.826 0.087 (0.664-1.028) 0.892 0.271 (0.728-1.093) 0.863 0.008 (0.774-0.963)
Middle InQ 0.785 0.018 (0.642-0.960) 0.885 0.137 (0.753-1.040) 0.806 0.001 (0.706-0.920)
4th InQ 0.691 0.000 (0.578-0.826) 0.793 0.007 (0.671-0.937) 0.755 0.000 (0.671-0.849)
Lowest InQ 0.620 0.000 (0.520-0.739) 0.675 0.000 (0.558-0.818) 0.626 0.000 (0.558-0.701)
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the survival gap for oral cavity cancers.
One possible explanation for this difference in time
trend relates to the relationship between HPV-positive
tumors and SES. To date, there has been no direct evi-
dence to suggest whether HPV-positive HNCs are more
common in high or low SES individuals. The widening
gap in survival between the highest and lowest incomeTable 4 Changes in 2-year survival and socio-economic status
Oropharyngeal
n = 7022
OR p-value 95% CI OR
CY 1991 1.000 1.000
CY 1996 1.142 0.402 (0.837-1.558) 1.208
CY 2001 1.458 0.012 (1.087-1.954) 1.240
Age at 0.952 0.000 (0.948-0.957) 0.963
Smoking 0.763 0.001 (0.651-0.895) 0.858
Highest InQ 1.000 1.000
2nd InQ 1.012 0.952 (0.697-1.468) 0.944
Middle InQ 0.850 0.351 (0.605-1.195) 1.024
4th InQ 0.754 0.037 (0.578-0.983) 0.906
Lowest InQ 0.767 0.063 (0.580-1.014) 0.830
2nd InQx96 0.725 0.128 (0.479-1.097) 0.959
2nd InQx01 0.795 0.267 (0.531-1.191) 0.879
Middle InQx96 1.060 0.797 (0.680-1.654) 0.856
Middle InQx01 0.757 0.118 (0.534-1.073) 0.765
4th InQx96 1.022 0.901 (0.727-1.437) 0.854
4th InQx01 0.764 0.156 (0.528-1.108) 0.793
Lowest InQx96 0.768 0.143 (0.540-1.093) 0.774
Lowest InQx01 0.722 0.050 (0.521-1.000) 0.717quintile for oropharyngeal cancer in our study over time
may serve as indirect evidence that HPV-positive HNCs
may be more common in higher SES groups. This is
potentially confirmed by the absence of such a time trend
in cancers that are not as associated with HPV as
oropharynx cancer related to HPV (oral cavity, naso-
pharynx, hypopharynx, and larynx). This potential as-
sociation between higher socioeconomic status andfor head and neck cancers
Oral cavity Naso/hypo/laryngeal
n = 8541 n = 14665
p-value 95% CI OR p-value 95% CI
1.000
0.193 (0.909-1.607) 1.043 0.681 (0.852-1.277)
0.206 (0.889-1.731) 1.028 0.864 (0.753-1.403)
0.000 (0.959-0.966) 0.969 0.000 (0.966-0.971)
0.020 (0.753-0.976) 0.945 0.374 (0.835-1.070)
0.779 (0.631-1.411) 0.859 0.112 (0.712-1.036)
0.872 (0.765-1.370) 0.793 0.036 (0.639-0.985)
0.592 (0.633-1.298) 0.825 0.071 (0.669-1.017)
0.346 (0.563-1.223) 0.688 0.002 (0.544-0.869)
0.839 (0.639-1.440) 0.962 0.811 (0.697-1.327)
0.595 (0.548-1.412) 1.070 0.625 (0.815-1.405)
0.408 (0.592-1.238) 0.960 0.772 (0.731-1.262)
0.152 (0.530-1.104) 1.113 0.549 (0.784-1.580)
0.410 (0.588-1.242) 0.865 0.292 (0.659-1.133)
0.342 (0.492-1.279) 0.904 0.549 (0.649-1.259)
0.236 (0.507-1.182) 0.859 0.269 (0.655-1.125)
0.139 (0.461-1.115) 0.899 0.559 (0.628-1.285)
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studies.
Our study had several limitations. First, no direct in-
formation about HPV-positivity in tumors was available,
making any inference about the influence of HPV on the
SES-survival relationship an indirect one. Second, we
did not possess individual-level income data, and thus
used DA-level information on household income as a
substitute, which is less precise than individual-level in-
formation. Furthermore, while household income re-
flects income from all sources, including pensions and
investment income, SES could be measured more accur-
ately with individual-level information on other determi-
nants of SES such as education level and occupation.
Income alone may be biased in favor of current SES ra-
ther than long-run SES. Finally, there was not sufficient
staging information available in the CCR dataset to allow
for us to control for stage at presentation by sub-site. As
a result, inferences on differential survival by HNC sub-
site assume that stage at presentation is not different for
the different sub-sites.
Conclusions
Overall survival, without controlling for smoking, for
oropharyngeal cancer increased dramatically from 1992–
2005 in Canada. A smaller magnitude increase in sur-
vival was seen for oral cavity cancer, and no change was
seen for cancer in other head and neck subsites. When
we controlled for smoking, the increase in survival for
oropharynx and oral cavity cancer was eliminated. Sur-
vival for all HNC subsites was strongly correlated with
SES, as measured by income quintile, with lower InQ’s
having lower survival than higher. Lastly, after control-
ling for smoking, the magnitude of the difference in
survival between the highest and lowest income quintiles
increased significantly over the time period studied for
oropharynx cancer, but did not statistically significantly
change for oral cavity cancer or other HNCs. These
data confirm a significant impact of socioeconomic
deprivation on overall survival for HNCs in Canada, and
may provide indirect evidence that HPV-positive HNCs
are more common in higher socioeconomic groups.
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